Yimin Zou

8PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Polymerisation mechanismsNanomedicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 23, 2026
Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer.

Mengting Chen, Xiangyu Chu, Haipeng Zhao

|Aug 06, 2025
Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress <i>via</i> enhancing T cell responses and sensitizing cells to gemcitabine.

Xin Huang, Hang Wu, Ke Zhu

|Aug 18, 2022
Minor adjustments in the chemical structures of pyridine derivatives induced different co-assemblies by O-H⋯N hydrogen bonds.

Peng Lei, Wendi Luo, Bin Tu

|May 13, 2022
Improving the inhibitory effect of CXCR4 peptide antagonist in tumor metastasis with an acetylated PAMAM dendrimer.

Changliang Liu, Hongyang Duan, Zijian Zhao

|May 11, 2022
Peptide conformation and oligomerization characteristics of surface-mediated assemblies revealed by molecular dynamics simulations and scanning tunneling microscopy.

Yimin Zou, Bin Tu, Lanlan Yu

|May 02, 2022
BSA-MnO<sub>2</sub>-SAL multifunctional nanoparticle-mediated M<sub>1</sub> macrophages polarization for glioblastoma therapy.

Fuming Liang, Ling Zhu, Chen Wang

Pageof 2

Frequent Collaborators

2 joint publications

Haiyan Xu

2 joint publications

Qiaojun Fang

2 joint publications

Xiaocui Fang

1 joint publications

Yu Zhang